Y.s.p.southeast Asia Holding Berhad

Quarterly rpt on consolidated results for the financial period ended 31/03/2024

General Meetings: Outcome of Meeting

Proposed Shareholders' Mandate for Existing Recurrent Related Party Transactions of a Revenue or Trading Nature

Annual Report & CG Report - 2023

YSPSAH - Notice of Book Closure

General Meetings: Notice of Meeting

First and Final Dividend

OTHERSProposed First and Final Single-tier Ordinary Dividend of 8.0 sen and Special Dividend of 3.0 sen per ordinary share

TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) : RECURRENT RELATED PARTY TRANSACTIONSProposed Shareholders' Mandate for Recurrent Related Party Transactions of a Revenue or Trading Nature

Quarterly rpt on consolidated results for the financial period ended 31/12/2023

$YSPSAH / 7178 (Y.S.P.SOUTHEAST ASIA HOLDING BERHAD)
CNA Insider host, Steven Chia travels to Malaysia to find out cheap medicines, with a visit to YSP's factory,
https://cutt.ly/nwZV7h2R

Quarterly rpt on consolidated results for the financial period ended 30/09/2023

OTHERSNotification on the Expiry of the Employees' Share Option Scheme ("ESOS")

Additional Listing Announcement /Subdivision of Shares

Additional Listing Announcement /Subdivision of Shares

@hokuan other "healthy" pharmaceutical companies could be the likes of $AHEALTH / 7090 (APEX HEALTHCARE BERHAD) and $YSPSAH / 7178 (Y.S.P.SOUTHEAST ASIA HOLDING BERHAD) , or even more indirectly pharma distribution co $DKSH / 5908 (DKSH HOLDINGS (MALAYSIA) BERHAD)

but these probably more indirectly than directly.

Additional Listing Announcement /Subdivision of Shares

Additional Listing Announcement /Subdivision of Shares

Additional Listing Announcement /Subdivision of Shares

Quarterly rpt on consolidated results for the financial period ended 30/06/2023

Additional Listing Announcement /Subdivision of Shares

5 Pharmaceutical Companies in Bursa Malaysia

Malaysia's Pharmaceutical sector has experienced steady growth over the years as population, expected lifespan, and healthcare expenditure has continued to increase.

Malaysia has always been actively promoting itself as a hub for clinical research and development (R&D). The country offers a favorable environment for conducting clinical trials, including a large patient pool, well-developed healthcare infrastructure, and internationally recognized research institutions.

Could the pharmaceutical and healthcare sector make good investments for you? Let’s take a look at 5 prominent pharmaceutical companies listed in Bursa Malaysia. If you had to pick one of them, which would you choose?

$AHEALTH / 7090 (APEX HEALTHCARE BERHAD) $NOVA / 0201 (NOVA WELLNESS GROUP BERHAD) $DPHARMA / 7148 (DUOPHARMA BIOTECH BERHAD) $KOTRA / 0002 (KOTRA INDUSTRIES BERHAD) $YSPSAH / 7178 (Y.S.P.SOUTHEAST ASIA HOLDING BERHAD)

Let us know in the comment section below!

Additional Listing Announcement /Subdivision of Shares

Additional Listing Announcement /Subdivision of Shares

Additional Listing Announcement /Subdivision of Shares

Additional Listing Announcement /Subdivision of Shares

Change in Boardroom - MR LEE SEN HUEI

Change in Nomination Committee - DR LEE FANG CHUAN @ LEE FANG CHEN

Change in Boardroom - DR LEE FANG CHUAN @ LEE FANG CHEN

General Meetings: Outcome of Meeting